Skip to content
MASS

908 Devices Inc.

908 Devices Inc. Q4 FY2025 earnings call

March 3, 2026 · fiscal period ended 2025-12

EPS · actual vs est

$-0.05 / $-0.06Beat +16.7%

Revenue · actual vs est

$17.4M / $13.4MBeat +29.4%
Ask about this call

Summary

Generated 2026-03-03

Management highlights

  • Kevin expressed appreciation to the team for execution and strategic transformation. Q4 revenue driven by Explorer gas identification device, new product Viper, and U.S. state/local adoption. Achieved positive adjusted EBITDA of $0.7 million in Q4. Full-year revenue $56.2 million, up 18% y-o-y. 22% y-o-y growth in recurring revenue, 35% of 2025 revenues. - Progress across three strategic focus areas: increasing adoption of devices for public health/safety, advancing next-gen analytical tools portfolio (Viper launched, MX908 enhanced), and strengthening financial position. - 2026 strategic focus areas: scale-proven platforms, extend platform leadership, strengthen revenue durability.
View in transcript ↓

Segment performance

In Q4 2025, revenue from continuing operations was $17.4 million, up 21% y-o-y. Handheld product and service revenue was $16 million, up 18% y-o-y. MX-908 product and service revenue was relatively flat. Program product and service revenue was $0.3 million. OEM and funded partnership revenue was $1 million. Recurring revenue was $5.5 million, 32% of total revenues. For full year 2025, revenue from continuing operations was $56.2 million, up 18% y-o-y. Recurring revenue was $19.5 million, 35% of total revenues. State and local sales grew 38% to ~$24 million, 43% of 2025 revenues.

View in transcript ↓

Guidance

  • Expect revenue in 2026 to be $64.5 - $67.5 million, 15% - 20% growth over 2025. - Handheld product and service revenue expected to grow 13% - 17% y-o-y, range $59.5 - $61.5 million. - OEM and funded partnerships expected ~$3 million. - ADCAP program revenue expected $2 - $3 million, likely in second half of 2026. - Adjusted gross margins expected mid to high 50% range for 2026, targeting margin expansion of at least 100 basis points. - Expect to cut 2025 adjusted EBITDA loss in half for 2026, reducing to mid-single-digit millions.
View in transcript ↓

Q&A highlights

Q: About relationship with Mountain Horse, why and economics?

A: Consolidated to one partner for procurement efficiency, predictability, etc. Danbury manufacturing helps with adjusted gross margin.

Q: On NextGen MX 908 platform?

A: Commercial launch later in 2026, disrupting themselves, high differentiation.

Q: On 2026 growth guidance range?

A: Drivers include Viper, Explorer, international growth, AVCAD.

Q: On Middle East conflict impact?

A: Not seeing meaningful immediate impact.

Q: On op expenses ticking higher?

A: Adding folks for state/local commercial efforts, international expansion, with state/local having more immediate contribution.

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS$-0.05$-0.06+16.7%
Revenue$17.4M$13.4M+29.4%

Transcript

March 3, 2026

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.